DBD
#1925
Diebold Nixdorf Incorporated Common stock
67.6 1 USD
0.00%
Market Price
Sector: Technology
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.40%
Monthly Change
-23.45%
6 month change
-14.57%
Year Change
+8.11%
Previous Close
67.8 8
Open
67.5 1
Low
67.4 4
High
67.8 9
Volume
131
Financials
- Market Capitalization 2.3 B
- Employee 20 K
- Founded N/A
- CEO Octavio Marquez
- Website www.dieboldnixdorf.com
- Headquarter Delaware, United States
- FIGI BBG01HVHYBT6
- Industry Software—Application
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
26.73
Price to sales ratio
0.66
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1915 |  VERX Vertex, Inc. - Class A Common Stock | 14.30 USD | +5.46% | +6.32% | +8.01% | -43.81% | 2.32 B USD | ||
| 1922 |  PRCH Porch Group, Inc. - Common Stock | 17.44 USD | +1.04% | +1.93% | +39.07% | +7.65% | 2.30 B USD | ||
| 1926 |  PLUS ePlus inc. - Common Stock | 87.66 USD | +1.74% | +0.98% | -5.33% | +17.32% | 2.29 B USD | ||
| 1943 |  BLKB Blackbaud, Inc. - Common Stock | 48.57 USD | +3.14% | +4.56% | +31.38% | -25.56% | 2.20 B USD |
Frequently asked questions about Diebold Nixdorf, Incorporated
What is the Diebold Nixdorf, Incorporated stock price today?
The current price of Diebold Nixdorf, Incorporated (DBD) is 67.61. Over the past 24 hours, the stock has changed by -0.40%. Follow the DBD chart for real-time price dynamics.
What is the stock ticker of Diebold Nixdorf, Incorporated?
Diebold Nixdorf, Incorporated trades under the ticker DBD. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Diebold Nixdorf, Incorporated stock going up?
DBD has changed by -1.40% over the last week, -23.45% over the last month, and +8.11% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Diebold Nixdorf, Incorporated?
Diebold Nixdorf, Incorporated currently has a market capitalization of 2.3 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Diebold Nixdorf, Incorporated earnings last quarter?
Last quarter, Diebold Nixdorf, Incorporated reported earnings of 0.45 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Diebold Nixdorf, Incorporated revenue for the last quarter?
Diebold Nixdorf, Incorporated reported quarterly revenue of 930.8 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Diebold Nixdorf, Incorporated net income for the last quarter?
Diebold Nixdorf, Incorporated reported net income of 15.5 M for the last quarter. The previous quarter showed 5 M, which means net income changed by +210.00%.
How many employees does Diebold Nixdorf, Incorporated have?
As of the latest available data, Diebold Nixdorf, Incorporated has 20 K employees. Workforce size can provide additional context about the company's scale and operations.
What is Diebold Nixdorf, Incorporated EBITDA?
Diebold Nixdorf, Incorporated EBITDA is 88.2 M, and its EBITDA margin is 9.48%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Diebold Nixdorf, Incorporated stock?
You can buy Diebold Nixdorf, Incorporated (DBD) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Diebold Nixdorf, Incorporated stock?
Investing in Diebold Nixdorf, Incorporated requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the DBD chart and related analysis on metatrader.com as part of your research.